Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Drawing on nothing more than Facebook activity, psychiatric AI can distinguish individuals headed for hospitalization with schizophrenia from those with worsening mood disorders such as clinical depression and bipolar states.
A women’s health technology company has received the FDA’s blessing to market deep learning-based software designed to help breast radiologists spot hard-to-find nascent cancers in 3D mammograms.
Both outcomes and costs may vary widely from one patient to the next even in hospitals with consistently strong quality scores. Machine learning can help optimize the selection process for each patient as an individual.
Only two of 156 scientific papers on AI published over the past 12 years used emotion as input data, according to a new literature review. And the reviewers focused on a specialty ripe for augmentation by artificial emotional intelligence: pregnancy health.
Psychological researchers have used AI to not only test a hypothesis on COVID-related behaviors but also to help come up with the hypothesis in the first place.
The healthcare AI startup founded by developers of the Apple Watch has been greenlit to market an AI-powered mobile application that lets radiologists interpret images and share the results with patients in real time.
